Coccidioidomycosis in solid organ transplantation

Janis E. Blair, Joy L. Logan

Research output: Contribution to journalArticle

147 Citations (Scopus)

Abstract

Coccidioidomycosis is an endemic fungal infection of the southwestern United States. Normally a self-limited infection in healthy hosts, coccidioidomycosis can become a serious complication in patients who have had solid organ transplantation. Among patients whose solid organ transplantation was complicated by coccidioidomycosis, the infection has a variety of clinical presentations. Disseminated disease is common and has substantial morbidity. Patients at risk for coccidioidal infection should be identified so that antifungal prophylactic therapy can be initiated. Treatment options include amphotericin B or azoles. Secondary prophylaxis is recommended because relapse is frequent.

Original languageEnglish (US)
Pages (from-to)1536-1544
Number of pages9
JournalClinical Infectious Diseases
Volume33
Issue number9
DOIs
StatePublished - Nov 1 2001

Fingerprint

Coccidioidomycosis
Organ Transplantation
Infection
Southwestern United States
Azoles
Mycoses
Amphotericin B
Morbidity
Recurrence
Therapeutics

ASJC Scopus subject areas

  • Immunology

Cite this

Coccidioidomycosis in solid organ transplantation. / Blair, Janis E.; Logan, Joy L.

In: Clinical Infectious Diseases, Vol. 33, No. 9, 01.11.2001, p. 1536-1544.

Research output: Contribution to journalArticle

Blair, Janis E. ; Logan, Joy L. / Coccidioidomycosis in solid organ transplantation. In: Clinical Infectious Diseases. 2001 ; Vol. 33, No. 9. pp. 1536-1544.
@article{83f014ce710a4215bf98810beade5f95,
title = "Coccidioidomycosis in solid organ transplantation",
abstract = "Coccidioidomycosis is an endemic fungal infection of the southwestern United States. Normally a self-limited infection in healthy hosts, coccidioidomycosis can become a serious complication in patients who have had solid organ transplantation. Among patients whose solid organ transplantation was complicated by coccidioidomycosis, the infection has a variety of clinical presentations. Disseminated disease is common and has substantial morbidity. Patients at risk for coccidioidal infection should be identified so that antifungal prophylactic therapy can be initiated. Treatment options include amphotericin B or azoles. Secondary prophylaxis is recommended because relapse is frequent.",
author = "Blair, {Janis E.} and Logan, {Joy L.}",
year = "2001",
month = "11",
day = "1",
doi = "10.1086/323463",
language = "English (US)",
volume = "33",
pages = "1536--1544",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Coccidioidomycosis in solid organ transplantation

AU - Blair, Janis E.

AU - Logan, Joy L.

PY - 2001/11/1

Y1 - 2001/11/1

N2 - Coccidioidomycosis is an endemic fungal infection of the southwestern United States. Normally a self-limited infection in healthy hosts, coccidioidomycosis can become a serious complication in patients who have had solid organ transplantation. Among patients whose solid organ transplantation was complicated by coccidioidomycosis, the infection has a variety of clinical presentations. Disseminated disease is common and has substantial morbidity. Patients at risk for coccidioidal infection should be identified so that antifungal prophylactic therapy can be initiated. Treatment options include amphotericin B or azoles. Secondary prophylaxis is recommended because relapse is frequent.

AB - Coccidioidomycosis is an endemic fungal infection of the southwestern United States. Normally a self-limited infection in healthy hosts, coccidioidomycosis can become a serious complication in patients who have had solid organ transplantation. Among patients whose solid organ transplantation was complicated by coccidioidomycosis, the infection has a variety of clinical presentations. Disseminated disease is common and has substantial morbidity. Patients at risk for coccidioidal infection should be identified so that antifungal prophylactic therapy can be initiated. Treatment options include amphotericin B or azoles. Secondary prophylaxis is recommended because relapse is frequent.

UR - http://www.scopus.com/inward/record.url?scp=0035502918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035502918&partnerID=8YFLogxK

U2 - 10.1086/323463

DO - 10.1086/323463

M3 - Article

VL - 33

SP - 1536

EP - 1544

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 9

ER -